Informação da revista
Vol. 90. Núm. 1.
Páginas 4-6 (janeiro - fevereiro 2014)
Vol. 90. Núm. 1.
Páginas 4-6 (janeiro - fevereiro 2014)
EDITORIAL
Open Access
Vitamin D deficiency (VDD): the culprit of cardiometabolic diseases?
Deficiência de vitamina D (DVD): o responsável por doenças cardiometabólicas?
Visitas
4587
Chaoxun Wang
Departamento de Endocrinologia, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Pudong, Shanghai, China
Este item recebeu
Informação do artigo
O texto completo está disponível em PDF
Referências
[1]
R.P. Heaney, R.L. Horst, D.M. Cullen, L.A. Armas.
Vitamin D3 distribution and status in the body.
J Am Coll Nutr., 28 (2009), pp. 252-256
[2]
S.R. Motiwala, T.J. Wang.
Vitamin D and cardiovascular risk.
Curr Hypertens Rep., 14 (2012), pp. 209-218
[3]
E. Stivelman, R. Retnakaran.
Role of vitamin D in the pathophysiology and treatment of type 2 diabetes.
Curr Diabetes Rev., 8 (2012), pp. 42-47
[4]
R. Scragg, M. Sowers, C. Bell.
Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey.
Am J Hypertens., 20 (2007), pp. 713-719
[5]
J.P. Forman, E. Giovannucci, M.D. Holmes, H.A. Bischoff-Ferrari, S.S. Tworoger, W.C. Willett, et al.
Plasma 25-hydroxyvitamin D levels and risk of incident hypertension.
Hypertension., 49 (2007), pp. 1063-1069
[6]
S.K. Bhandari, S. Pashayan, I.L. Liu, S.A. Rasgon, D.A. Kujubu, T.Y. Tom, et al.
25-hydroxyvitamin D levels and hypertension rates.
J Clin Hypertens (Greenwich)., 13 (2011), pp. 170-177
[7]
J.P. Forman, J.B. Scott, K. Ng, B.F. Drake, E.G. Suarez, D.L. Hayden, et al.
Effect of vitamin D supplementation on blood pressure in blacks.
Hypertension., 61 (2013), pp. 779-785
[8]
Zhao G, Ford ES, Li C. Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among U.S. adults without physician-diagnosed diabetes: NHANES, 2003-2006. Diabetes Care. 2010;33:344-7.
[9]
Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes. 2008;57: 2619-25.
[10]
P.R. von Hurst, W. Stonehouse, J. Coad, D. Vitamin.
supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial.
Br J Nutr., 103 (2010), pp. 549-555
[11]
C. Gagnon, Z.X. Lu, D.J. Magliano, D.W. Dunstan, J.E. Shaw, P.Z. Zimmet, et al.
Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab).
J Clin Endocrinol Metab., 97 (2012), pp. 1953-1961
[12]
G.N. Thomas, B. ó Hartaigh, J.A. Bosch, S. Pilz, A. Loerbroks, M.E. Kleber, et al.
Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
Diabetes Care., 35 (2012), pp. 1158-1164
[13]
T.J. Wang, M.J. Pencina, S.L. Booth, P.F. Jacques, E. Ingelsson, K. Lanier, et al.
Vitamin D deficiency and risk of cardiovascular disease.
Circulation., 117 (2008), pp. 503-511
[14]
S. Pilz, W. März, B. Wellnitz, U. Seelhorst, A. Fahrleitner-Pammer, H.P. Dimai, et al.
Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography.
J Clin Endocrinol Metab., 93 (2008), pp. 3927-3935
[15]
R. Kelishadi, S. Salek, M. Salek, M. Hashemipour, M. Movahedian.
Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial.
J Pediatr (Rio J)., 90 (2014), pp. 28-34
[16]
A. Salo, J.V. Logomarsino.
Relationship of vitamin D status and cardiometabolic risk factors in children and adolescents.
Pediatr Endocrinol Rev., 9 (2011), pp. 456-462
[17]
K.L. Margolis, R.M. Ray, L. Van Horn, J.E. Manson, M.A. Allison, H.R. Black, et al.
Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial.
Hypertension., 52 (2008), pp. 847-855
[18]
R. Jorde, Y. Figenschau.
Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels.
Eur J Nutr., 48 (2009), pp. 349-354
[19]
C. Wang.
Role of vitamin d in cardiometabolic diseases.
J Diabetes Res., 2013 (2013), pp. 243934
Copyright © 2013. Brasileira de Pediatria